{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:25:59Z","timestamp":1764433559379,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome is a severe adverse drug reaction marked by delayed hypersensitivity reactions causing skin and systemic complications. DRESS diagnosis is challenging due to the variety of clinical presentations and symptom overlap with other conditions. The perioperative period in these patients requires precise pharmacological strategies to prevent complications associated with this syndrome. The treatment of DRESS induced by unfractionated heparin during cardiopulmonary bypass (CPB) surgery presents some challenges that must be considered when selecting an anticoagulant to avoid side effects. In this case, bivalirudin, a direct thrombin inhibitor, is indicated as an alternative to heparin in patients undergoing CPB. However, in contrast to heparin\/protamine, there is no direct reversal agent for bivalirudin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of an 11-year-old male diagnosed with native aortic valve endocarditis and thrombosis in his left lower extremity. During valvular replacement surgery, systemic unfractionated heparin was administered. Postoperatively, the patient developed fever, eosinophilia and pruritic rash. Warm shock and elevated alanine transaminase (ALT) and aspartate transaminase (AST) levels followed, leading to the diagnosis of DRESS syndrome. Treatment with methylprednisolone resulted in complete resolution of symptoms. Seven years later, the patient was readmitted due to insufficient anticoagulation and a thrombus in the prosthetic aortic valve, presenting a recurrent DRESS episode due to the administration of unfractionated heparin, which was later replaced with low-molecular-weight heparin during hospitalization. Treatment with corticosteroids and antihistamines was initiated, resulting in the resolution of this episode. Ultimately, the patient required the Ross procedure. During this intervention the anticoagulation strategy was modified, unfractionated heparin was replaced with bivalirudin during the procedure and fondaparinux was administered during the postoperative period. This resulted in stable transaminases levels and no eosinophilia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The severity of DRESS Syndrome underscores the importance of early recognition, heightened monitoring, and a comprehensive approach tailored to each patient\u2019s needs. This particular case highlights the significance of this approach and may have a substantial clinical impact since it provides alternatives to heparin, such as bivalirudin and fondaparinux, in the anticoagulation strategy of CPB for patients who have a hypersensibility reaction to this medication; thus, enhancing clinical outcomes by minimizing risks linked to adverse drug reactions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-024-02722-x","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T10:01:51Z","timestamp":1713348111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heparin-induced DRESS syndrome in a paediatric patient and successful anaesthetic management in cardiovascular bypass surgery: case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Laura","family":"Pe\u00f1a-Blanco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Guti\u00e9rrez-Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix Ram\u00f3n","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Barrag\u00e1n-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Beltr\u00e1n-Villegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"L\u00f3pez-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Villa-Hincapi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Uma\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"2722_CR1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1525-1470.2009.00870.x","volume":"26","author":"BD Newell","year":"2009","unstructured":"Newell BD, Moinfar M, Mancini AJ, Nopper AJ. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatr Dermatol. 2009;26:536\u201346.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"2722_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21911\/aai.444","volume":"18","author":"S Bah\u00e7eci","year":"2020","unstructured":"Bah\u00e7eci S, Can D. Dress syndrome. Asthma Allergy Immunol. 2020;18(1):1\u20139. https:\/\/doi.org\/10.21911\/aai.444.","journal-title":"Asthma Allergy Immunol"},{"issue":"2","key":"2722_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","volume":"7","author":"AR Wolfson","year":"2019","unstructured":"Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module. J Allergy Clin Immunol Pract. 2019;7(2):633\u201340.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"2722_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.alit.2016.04.001","volume":"65","author":"A Hiransuthikul","year":"2016","unstructured":"Hiransuthikul A, Rattananupong T, Klaewsongkram J, Rerknimitr P, Pongprutthipan M, Ruxrungtham K. Drug- induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS): 11 years retrospective study in Thailand. Allergol Int. 2016;65(4):432\u20138.","journal-title":"Allergol Int"},{"issue":"3","key":"2722_CR5","doi-asserted-by":"publisher","first-page":"100673","DOI":"10.1016\/j.waojou.2022.100673","volume":"16","author":"A Calle","year":"2023","unstructured":"Calle A, Mar\u00eda N, Aguirre JC, Ardila. Dress syndrome: a Literature Review and Treatment Algorithm. World Allergy Organ J. 2023;16(3):100673. https:\/\/doi.org\/10.1016\/j.waojou.2022.100673.","journal-title":"World Allergy Organ J"},{"issue":"3","key":"2722_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","volume":"68","author":"T Shiohara","year":"2019","unstructured":"Shiohara T, Mizukawa Y. Drug-Induced Hypersensitivity Syndrome (Dihs)\/Drug reaction with Eosinophilia and systemic symptoms (dress): an update in 2019. Allergology Int. 2019;68(3):301\u20138. https:\/\/doi.org\/10.1016\/j.alit.2019.03.006.","journal-title":"Allergology Int"},{"issue":"1","key":"2722_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","volume":"36","author":"SA Walsh","year":"2011","unstructured":"Walsh SA, Creamer D. Drug reaction with Eosinophilia and systemic symptoms (dress): a clinical update and review of current thinking. Clin Exp Dermatol. 2011;36(1):6\u201311. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03967.x.","journal-title":"Clin Exp Dermatol"},{"key":"2722_CR8","doi-asserted-by":"publisher","unstructured":"Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume J-C, Chosidow O, et al. Twelve-year analysis of severe cases of drug reaction with Eosinophilia and systemic symptoms. Arch Dermatol. 2009;145(1). https:\/\/doi.org\/10.1001\/archderm.145.1.67.","DOI":"10.1001\/archderm.145.1.67"},{"issue":"1","key":"2722_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","volume":"81","author":"V Descamps","year":"2014","unstructured":"Descamps V. Dress syndrome. Joint Bone Spine. 2014;81(1):15\u201321. https:\/\/doi.org\/10.1016\/j.jbspin.2013.05.002.","journal-title":"Joint Bone Spine"},{"key":"2722_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jaad.2013.01.033","volume":"68","author":"Z Husain","year":"2013","unstructured":"Husain Z, Reddy BY, Schwartz RA. Dress syndrome. J Am Acad Dermatol. 2013;68:5. https:\/\/doi.org\/10.1016\/j.jaad.2013.01.033.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2722_CR11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"SH Kardaun","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC. Drug reaction with Eosinophilia and systemic symptoms (dress): an original multisystem adverse drug reaction. Results from the prospective Regiscar Study. Br J Dermatol. 2013;169(5):1071\u201380. https:\/\/doi.org\/10.1111\/bjd.12501.","journal-title":"Br J Dermatol"},{"issue":"4","key":"2722_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.18176\/jiaci.0480","volume":"30","author":"R Caba\u00f1as","year":"2020","unstructured":"Caba\u00f1as R, Ram\u00edrez E, Sendagorta E, Alamar R, Barranco R, Blanca-L\u00f3pez N, Do\u00f1a I, et al. Spanish guidelines for diagnosis, management, treatment, and Prevention of Dress Syndrome. J Investig Allergol Clin Immunol. 2020;30(4):229\u201353. https:\/\/doi.org\/10.18176\/jiaci.0480.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2722_CR13","doi-asserted-by":"publisher","unstructured":"Kunst G, Milojevic M, Boer C, Filip MJJ, De Somer T, van den Gudbjartsson TJ, Jones et al. 2019 Eacts\/EACTA\/EBCP Guidelines on Cardiopulmonary Bypass in Adult Cardiac Surgery. British Journal of Anaesthesia 123, no. 6 (2019): 713\u201357. https:\/\/doi.org\/10.1016\/j.bja.2019.09.012.","DOI":"10.1016\/j.bja.2019.09.012"},{"key":"2722_CR14","unstructured":"Kumar V, Abbas AK, Aster JC. Robbins & Cotran Pathologic Basis of Disease. Elsevier Saunders; 2015."},{"issue":"12","key":"2722_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1398-9995.2006.01227.x","volume":"61","author":"AJ Bircher","year":"2006","unstructured":"Bircher AJ, Harr T, Hohenstein L, Tsakiris DA. Hypersensitivity reactions to anticoagulant drugs: diagnosis and Management options. Allergy. 2006;61(12):1432\u201340. https:\/\/doi.org\/10.1111\/j.1398-9995.2006.01227.x.","journal-title":"Allergy"},{"issue":"2","key":"2722_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.athoracsur.2017.09.061","volume":"105","author":"L Shore-Lesserson","year":"2018","unstructured":"Shore-Lesserson L, Baker RA, Ferraris VA, Greilich PE, Fitzgerald D, Roman P, Hammon JW. The Society of thoracic surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of Extracorporeal Technology: clinical practice guidelines \u2217 \u2014Anticoagulation during cardiopulmonary bypass. Ann Thorac Surg. 2018;105(2):650\u201362. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.09.061.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"2722_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1051\/ject\/200537296","volume":"37","author":"JJ Veale","year":"2005","unstructured":"Veale JJ, Harry M, McCarthy G, Palmer, Dyke CM. Use of Bivalirudin as an anticoagulant during cardiopulmonary bypass. J Extracorpor Technol. 2005;37(3):296\u2013302. https:\/\/doi.org\/10.1051\/ject\/200537296.","journal-title":"J Extracorpor Technol"},{"issue":"3","key":"2722_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jtcvs.2005.09.057","volume":"131","author":"CM Dyke","year":"2006","unstructured":"Dyke CM, Smedira NG, Koster A, Aronson S, McCarthy HL, Kirshner R, Lincoff AM, Spiess BD. A comparison of Bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the evolution-on study. J Thorac Cardiovasc Surg. 2006;131(3):533\u201339. https:\/\/doi.org\/10.1016\/j.jtcvs.2005.09.057.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"2722_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.athoracsur.2006.09.038","volume":"83","author":"A Koster","year":"2007","unstructured":"Koster A, Dyke CM, Aldea G, Smedira NG, McCarthy HL, Aronson S, Hetzer R, Avery E, Spiess B, Michael Lincoff. Bivalirudin during cardiopulmonary bypass in patients with previous or Acute Heparin-Induced Thrombocytopenia and Heparin antibodies: results of the choose-on trial. Ann Thorac Surg. 2007;83(2):572\u201377. https:\/\/doi.org\/10.1016\/j.athoracsur.2006.09.038.","journal-title":"Ann Thorac Surg"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-02722-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-024-02722-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-02722-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T10:04:12Z","timestamp":1713348252000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-024-02722-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2722"],"URL":"https:\/\/doi.org\/10.1186\/s13019-024-02722-x","relation":{},"ISSN":["1749-8090"],"issn-type":[{"type":"electronic","value":"1749-8090"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"23 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval was needed for the generation of this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent from the patient was received for participation and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}